OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Explore linked clinical trials.61 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Early phase 1 | 2026-10-06 | NCT07089940 | |
| Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, head and neck carcinoma, hypopharyngeal carcinoma, laryngeal carcinoma, laryngeal disorder, laryngeal neoplasm, mouth disorder, neoplasm, oral cavity carcinoma, oropharyngeal carcinoma, otorhinolaryngologic disease, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 4 | 2026-10-05 | NCT07857655 | |
| Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-10-05 | NCT07548983 | |
| Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder | hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | Recruiting | Early phase 1 | 2026-09-28 | NCT07844694 | |
| Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, diffuse large B-cell lymphoma, follicular lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary mediastinal large B-cell lymphoma, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-09-23 | NCT06784167 | |
| Feasibility of FMISO in Brain Tumors | IDH Wild Type Glioblastoma | Recruiting | Phase 2 | 2026-09-18 | NCT03649880 | |
| Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute monocytic leukemia, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-09-16 | NCT06504459 | |
| Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Recruiting | Not stated | 2026-09-16 | NCT05081024 | |
| Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study | Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast carcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, in situ carcinoma, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-09-15 | NCT04993313 | |
| Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, castration-resistant prostate carcinoma, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT02522715 | |
| Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System | Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, cranial nerve neuropathy, metastatic malignant neoplasm in the brain, neoplasm, nervous system disorder | Recruiting | Phase 2 | 2026-09-14 | NCT03270059 | |
| Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Recruiting | Not stated | 2026-09-08 | NCT06562777 | |
| Targeted Pathway Inhibition in Patients With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Early phase 1 | 2026-09-04 | NCT04005690 | |
| Mammogram Pretreatment With Ulipristal Acetate | Breast Density; Mammography Screening | Recruiting | Phase 2 | 2026-09-03 | NCT07434128 | |
| Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool | Neoplasms by Site, Thoracic Neoplasms, lung carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-09-02 | NCT05407168 | |
| Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT | Embolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder | Recruiting | Phase 2 | 2026-08-31 | NCT07498517 | |
| Use Of Indocyanine Green In Pancreas Surgery | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pancreatic Carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2026-08-31 | NCT06084013 | |
| An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial | Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-08-28 | NCT07278440 | |
| CREATE: Art for Children With Cancer | Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm | Recruiting | Not applicable | 2026-08-25 | NCT06342453 | |
| Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not stated | 2026-08-14 | NCT07726602 | |
| Pathogenesis of Hematologic Malignancies | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, acute leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, myelodysplastic syndrome | Enrolling by invitation | Not stated | 2026-08-13 | NCT01728402 | |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal disorder, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-07-16 | NCT05705492 | |
| Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Not yet recruiting | Not applicable | 2026-07-15 | NCT07664241 | |
| Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-07-15 | NCT04267887 | |
| Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-07-14 | NCT04659616 |